A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of ...

Danish pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) submitted a Citizen Petition to the FDA requesting the exclusion of ...

2024 Future of Healthcategory Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea December 20, 2024 Future of Healthcategory US FDA approves Vertex Pharma's ...

US FDA approves Hikma's generic version of Novo's diabetes drug Victoza Healthcare & Pharmaceuticalscategory ... on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive ...

In its Citizen Petition to the FDA, Novo Nordisk argued that there is no clinical need to allow compounding for liraglutide, ...

Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...